(Surgeon i/c Thyroid Clinic): Primary thyrotoxic goitre offers no difficulty in diagnosis and we find thiouracil invaluable for increasing safety of operation in these patients. It has eliminated the necessity for stage operations in the very severe cases although it increases the technical difficulties.
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President-L. R. BROSTER, O.B.E., M.Ch. [March 26, 1947] DISCUSSION ON THE TREATMENT OF TOXIC GOITRE Mr. J. E. Piercy (Surgeon i/c Thyroid Clinic): Primary thyrotoxic goitre offers no difficulty in diagnosis and we find thiouracil invaluable for increasing safety of operation in these patients. It has eliminated the necessity for stage operations in the very severe cases although it increases the technical difficulties.
We feel that the secondary nodular thyrotoxic goitre which leads insidiouslyto cardiac damage culminating in paroxysmal or established auricular fibrillation is the type which most needs recognition, particularly the apparently non-toxic nodular gland with few symptoms other than tiredness, irritability and occasional palpitation, often with a basal metabolic rate within normal limits.
There is a very great difference clinically between primary and secondary toxic goitre, and I have yet to find a patient with a nodular goitre giving a history suggestive of primary Graves' disease earlier in life. The importance of this must be appreciated when we find that 22 % of 1,000 patients with nodular goitres had developed auricular fibrillation by the time they were sent for operation-40 % between the ages of 50 and 60, and 30 % between 40 and 50. Of these 220 patients 78 % were discharged with normal rhythm after operation, either occurring spontaneously, or after a short course of quinidine. They do not include the many patients with minimal thyrotoxicosis, some showing signs of pressure symptoms only, who developed a transient post-operative fibrillation. These were at the point of developing paroxysmal or established fibrillation before operation and this should not be looked upon as a complication of the operation but as evidence that they were at a late stage in the disease.
Our procedure is one of close collaboration between physician and surgeon and carefully organized team-work. The pre-and post-operative procedure depends solely on the individual merits of each case. There can be no uniformity in regard to the pre-operative period of rest and iodine or in the type of operation performed.
We feel that ligation of the inferior thyroid arteries lessens the possibility of recurrence because we have had none to our knowledge in 550 patients treated in the past seven years, whereas in the previous seven years 750 operations were performed and the vessels were not ligated and 6% of these patients had recurrences. A recurrence in secondary toxic goitre is often due to the fact that the opposite lobe was not explored and to its being really a case of continued growth in the unexplored lobe.
SEPT. Results.-In the average patient a return to normal or near normal health can be expected, whilst a large measure of recovery can be anticipated even in severely toxic patients and in those with complications. Thyrotoxicosis commonly occurs in the highly-strung, sensitive type of person and though thyroid balance may be regained by operation, the constitutional make-up is not altered. It is generally recognized, however, that the nursing profession is an exceptionally arduous and exacting one and the fact that of 67 nurses who underwent partial thyroidectomy all returned to full duty is an indication of the effectiveness of the operation.
We have not used thiouracil at our clinic as treatment so I cannot pretend to have any experience of it as such. I am, perhaps, biased therefore as my only experience of the drug, apart from pre-operative and diagnostic use, is from those many cases of thiouracil failure and intolerance, sent to us for operation from hospitals both in London and in the Provinces. These patients were many and varied, males and females with primary and nodular goitres, some having had the drug for as little as three weeks and some up to two years. The majority had improved but treatment had been stopped for various reasons, including leucopenia, nausea and vomiting, thrombocytopenia, attacks of tetany, cedema of legs with urticaria, increasing size of gland and vomiting, leucopenia with precordial pain, recurrence of symptoms while under treatment, lack of response to thiouracil, continued auricular fibrillation with evidence of heart failure, and failure to co-operate with the physician.
All of these patients had been treated in hospitals under medical supervision, one of them for as long as one and three-quarter years, and I am certain that every effort had been made for a successful trial before the patients were sent to us for operation.
In surgery, not only is the thyrotoxicosis dealt with rapidly, once and for all, but also the goitre, which is liable to cause pressure symptoms, to be subject to hmemorrhage, occasionally to become malignant, and even by its mere presence to cause endless worry and anxiety. Moreover, the risk of future auricular fibrillation is practically removed.
To my mind surgery offers a more certain and more rapid cure than does thiouracil and the mortality is no greater. Physiological experiment therefore leads us to expect that if this drug is given to a patient with a toxic goitre it will be possible to reduce or abolish the manifestations of thyrotoxicosis. But since there is no evidence that thiouracil has any permanent effect on the thyroid it is to be expected that if the drug is discontinued the symptoms will immediately recur, unless by that time a natural remission of the disease has taken place. We shall certainly not expect any reduction in the size of the goitre and shall not be surprised to find that it becomes larger. We shall also not expect any amelioration of exophthalmos or ophthalmoplegia, since there is reason to believe that they are not the result of thyrotoxicosis as such.
It is obvious that the practical utility of the drug will depend, first, on its ability to control the symptoms of thyrotoxicosis; secondly, on. its toxicity; and, thirdly, on the frequency with which natural remission occurs. If thiouracil is to supplant surgery as the standard treatment of toxic goitre it must be shown that it can control thyrotoxicosis as effectively as thyroidectomy and that it is no more dangerous than the operation. If these postulates can be fulfilled then thiouracil is clearly a useful method of tiding a patient over a relatively brief phase of thyrotoxicosis, but it would still not be a very acceptable form of therapy if it had to be continued for a lifetime. Most patients would probably prefer to swallow pills for a limited period rather than undergo a major operation; but they would probably prefer the operation to the prospect of remaining under close medical supervision for the rest of their lives. Much therefore depends on the natural course of the disease.
For the most part the theoretical forecasts have been confirmed by clinical experience. The only major exception has been the enlargement of the goitre which might be expected to occur regularly during thiouracil treatment but which in fact appeared in only 8% of our cases. Usually, but not invariably, when the goitre enlarges symptoms of myxcedema also appear. Lowering the dose of thiouracil abolishes the signs of myxcedema, and the gland reverts to its previous size. It seems that in order to cause enlargement of the goitre one has to give a dose greater than that which is necessary to control the thyrotoxicosis. In other words, when enlargement of a goitre occurs during thiouracil treatment it is simply an indication of overdosage.
The control of thyrotoxicosis by thiouracil which is theoretically to be expected obtains also in practice. The short-term effects of this drug are too well known to need further description. Only in cases which have had much iodine do we fail to get a well-marked response within a few weeks of the start of treatment. However, iodine can also produce a prompt response when given to a thyrotoxic patient for the first time, and it is clearly necessary to show that the control exercised by thiouracil can be maintained for long periods. Some Proceedings of the Royal Society of Mlledicine that the patients were free of all thyrotoxic symptoms and had pulse-rates of 80 or less. It will be seen that about one-third of the cases in both series attained this standard throughout the period of observation. The remainder either had slight symptoms, such as occasional palpitations, or their pulse-rates were a little over 80. In botlh series all patients obtained considerable benefit from their treatment and had resumed their normal occupations. It was also found that the average weight curves of the two series ran closely parallel. We concluded from these observations that thiouracil maintains its control for periods of up to thirty months, and that that control is of the same order of efficacy as that produced by thyroidectomy.
We have been able to study 29 patients who have been kept under observation for six months or more since thiouracil was stopped ( fig. 1) We think therefore that thiouracil is capable of controlling thyrotoxicosis and that the disease is one in which natural remission occurs often enough for a remedy of this kind to have its uses.
The common complications of thiouracil therapy are skin rashes, drug fever and leucopenia. However, these conditions do not amount to much more than a nuisance and at their worst may lead to discontinuance of thiouracil. Agranulocytosis is a very different matter. Its high death-rate and unexpected onset make it one of the most alarming conditions to be encountered in medicine. It is the cause of all the recorded deaths from thiouracil. There is at present no known way of preventing agranulocytosis, but alertness and promptitude in diagnosis and treatment will do much to prevent it being fatal. It is very necessary that patients on thiouracil should be warned to report at once if they develop fever or a sore throat and that they should immediately discontinue the drug. In such an event a blood-count must be done immediately and if no polymorphs are present penicillin should be started at once.
If a patient with agranulocytosis can be protected from infection during the critical period he will probably survive.
But although agranulocytosis is alarming it is fortunately rare. 343) , show that the death-rate due to thiouracil amounts to about 0-5% of all cases treated. These figures include the early cases when agranulocytosis was not anticipated, and not all the patients with agranulocytosis were treated with penicillin. The present day mortality-rate is therefore probably less. Hence it may be said that the mortalityrate of thiouracil is at least as small as that of thyroidectomy in the hands of an expert surgeon.
In summary, thiouracil can be said to be a safe and effective method of keeping thyrotoxicosis under control. It has no curative action and therefore is only useful in cases in which the disease is not likely to last an inordinately long time. So far as our early experience goes it looks as if a fairly large proportion of cases of toxic goitre will be found to fall into this class.
If this new agent is to be compared with the well-established method of subtotal thyroidectomy it is clear that the comparison must depend on two circumstances: first, the type of surgery with which it is to be compared, and secondly the type of case which is being treated.
Subtotal thyroidectomy can be a very difficult operation. The safety with which it can be performed depends not only on the skill of the surgeon and his team, but also on his familiarity with the operation. By the time a surgeon has done several hundred thyroidectomies we can safely assume that his mortality-rate has fallen to the region of1% or less. Most general surgeons do not acquire this degree of experience and their mortality is correspondingly higher than that of their colleagues who have made a special study of the operation. It follows that thyroidectomy in the hands of an expert is about as safe as treatment with thiouracil, but that thyroidectomy by surgeons without much experience of the operation is less safe than thiouracil-in some cases much less safe. In places where specialized surgery is not available, therefore, a physician may be well advised to treat all his cases with thiouracil, in the expectation that by so doing he will be savinglives.
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When expert surgery is available we can afford to exercise more discrimination. Here surely the aim should be to learn to distinguish the short-term from the longterm cases. By the long-term cases I mean those patients whose thyrotoxicosis seems likely to last many years and for whom thyroidectomy would be a more appropriate remedy. We have, for example, under our care a man of 57, whose thyrotoxicosis began first in 1917. A partial thyroidectomy was performed and he remained well until 1933 when the symptoms returned. He has now been under treatment with thiouracil continuously for two years. So long as the dose is maintained at 100 mg. daily he remains well, but thyrotoxic symptoms have appeared on the three occasions when it has been decreased below this level. It now seems as if he will need thiouracil for many years-perhaps indefinitely. This is a case in which a further thyroidectomy might have been a more appropriate treatment.
In toxic nodular goitre, too, we are dealing with a condition in which natural remission is unlikely, for the symptoms seem to be related as much to the patient's age and cardiac state as to the state of the goitre itself. In these patients an element of mechanical obstruction is very common and there are therefore double grounds for supposing that they are best dealt with by thyroidectomy.
As a contrast I will quote the case of a woman aged 42, who started treatment in April 1944. Initially she had an easily palpable diffuse goitre and unilateral lid retraction. The initial sleeping pulse-rate was 110, and the B.M.R. + 53 %. She made a good response in the first month of treatment and was afterwards maintained free of symptoms on 50 mg. daily, and then on 50 mg. on alternate days. Thiouracil was stopped after treatment had continued for nine months in all. She has been observed for a further two years since then. She says she has never felt so well in her life. Her goitre is no longer visible and scarcely palpable; and the lid retraction has gone. She has gained 21 stones in weight, and her pulse-rate at the last six attendances has varied between 68 and 80. It seems to me that thiouracil in such cases is the best form of therapy. Dr. A. M. Nussey: My remarks are based on experience in 75 cases treated with thiouracil in the course of three and a half years. I would like to emphasize that anyone attempting to treat cases of thyrotoxicosis with thiouracil should follow them right through, for years, if need be.
After a preliminary B.M.R., white cell and polymorph counts, every patient is given the choice of surgery or medicine and, if thiouracil is preferred, is warned of the possible dangers. I used to admit patients for at least a week, and longer if such complications as congestive heart failure and auricular fibrillation were present, but now practically all, with exception of the so-called thyro-cardiacs, are treated as out-patients, and those who are gainfully employed are allowed to go on working while the treatment is progressing. They are seen at weekly intervals twice or three times, then every other week, then every third week and finally, while the treatment lasts, not less than once in every four weeks. At such a visit the patients are assessed in a general way, white cell and polymorph counts are done, the neck measured and weight recorded. In the light of experience I now treat all patients for not less than eight months, even if they respond very rapidly. After treatment stops they are followed up every two months and then once every three months, and with few exceptions, their co-operation has been very good. At present I have thirty patients, half of whom had severe or very severe symptoms and the other half moderate or mild, who had remissions for not less than five months after periods of treatment varying from three to fifteen months, the average being about seven months. Four of those had relapses which necessitated more than one course. Ten have been free of symptoms for longer than two years, the longest being two years nine months, and eleven for more than a year. On the other hand one of my first patients has had to have thiouracil with short remissions for over three years. Relapses, which are often preceded by emotional stress, do, as a rule, respond to further courses of treatment. With thiouracil the thyroid gland softens slightly, and only rarely does it become smaller. In many patients there is a slight enlargement, and in some of the early ones, where we used larger doses than we are accustomed to do now, the neck swelled up considerably, though the process was found to be reversible when the dose of the drug was reduced. The neck measurements already mentioned serve as a rough guide, but of course some of the increase in circumference is often due to the quite appreciable gain in weight observed in most cases.
I have not found exophthalmos much affected by the treatment, but in one patient unilateral exophthalmos regressed completely with thiouracil. Seven patients had auricular fibrillation and the rhythm returned to normal in four, one with the aid of quinidine, but in the three others there has been no change. Two patients conceived in the remission stage (one of those had had a stillbirth before thiouracil treatment) and both had healthy children. Another was treated for five months ending six weeks before term and she was delivered of a normal baby.
Complications of a minor type like fleeting macular rashes, enlargement of salivary glands and a tendency to leucopenia were met in about 10 % of the patients, but hardly at all in the last twenty. It is fair to point out that with such prolonged treatment all kinds of symptoms may arise, and some may be unjustly blamed on thiouracil. Two serious complications occurred, one in a woman of 59 who developed almost complete agranulocytosis and who eventually responded to intravenous pyridoxine, and another in a female diabetic of 65 who had an intense maculo-papular rash, splenomegaly and fever, without a drop in the white cell count. Two patients were operated on because thiouracil failed to control the disease fully but in both, after an extensive ablation of the thyroid, further treatment with thiouracil was required. A third was operated on at the patient's request after she suffered a relapse and a fourth is awaiting operation because of her lack of co-operation.
The usual contra-indications to the use of thiouracil are:
(1) Where the patient, for cosmetic or other reasons, expresses a preference for surgery; (2) where the gland exerts pressure; (3) where, in the course of treatment, serious complications arise, such as agranulocytosis and recurring rashes with fever; (4) where the disease cannot be controlled without pushing the drug to dangerous limits; (5) where co-operation by the patient is lacking.
At present I would suggest three years as an arbitrary period for length of treatment, after which only the patient's express wish to avoid surgery. would justify further use of thiouracil.
Mr. R. Vaughan Hudson: Thiouracil is a sign-post on the road to medical treatment but is not the complete answer to our problems. It is essential that the effects of thiouracil be fully investigated, and the indication for its use and the knowledge of its limitations made known. On the other hand the random use of thiouracil must be deprecated. The patient should be warned of its uncertainties and of its dangers, and treatment only undertaken by competent physicians, with a knowledge of the vagaries of thyrotoxicosis, who will undertake a full investigation of their patients, and keep them under supervision for a number of years.
Failures of prolonged thiouracil treatment which eventually come to operation render the surgical technical problem much more difficult. Mortality and morbidity in these cases should be credited to the results of medicine rather than be attributed entirely to surgery.
Although a division of the cases into primary and secondary thyrotoxicosis is useful I do not consider that there is any essential difference between the two. For instance in 150 personal cases of arrhythmia, we found that the arrhythmia was due to primary thyrotoxicosis more commonly than to secondary thyrotoxicosis and nodular goitre. Dr. A. C. Crooke: Improvement in the results of medical treatment of toxic goitre may be anticipated and it is unfair to compare the present results of thiouracil therapy, which is still in its infancy, with surgery, which has, perhaps, reached the peak of its perfection. Rather the results of thiouracil therapy to-day should be compared with surgery in its infancy, when it will be realized how valuable a drug we have to deal with.
New advances are being made and in 1943 Astwood, Bissell and Hughes had reported on the comparison of 220 compounds with thiouracil, 115 of these had detectable antithyroid activity and 15 were more potent than thiouracil. The most active of them were 6-n propyl thiouracil, which was eleven times, and 6-n benzyl thiouracil, which was ten times as active as thiouracil. In 1946 Astwood and Van der Laan reported on the treatnient of 100 unselected patients with propyl thiouracil, none of whom had any toxic reactions. If this work is confirmed by others, then we have in propyl thiouracil a drug which is as simple, as safe and as effective for the treatment of thyrotoxicosis as thyroid extract is for the treatment of thyroid insufficiency.
